Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
23,519,400
-
Shares change
-
-822,775
-
Total reported value, excl. options
-
$68,667,507
-
Value change
-
-$4,346,817
-
Number of buys
-
35
-
Number of sells
-
-46
-
Price
-
$2.92
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2018
113 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q4 2018.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,519,400 shares
.
Largest 10 shareholders include JPMORGAN CHASE & CO (3,995,794 shares), BlackRock Inc. (2,935,508 shares), BAKER BROS. ADVISORS LP (2,677,818 shares), Vanguard Group Inc (1,955,717 shares), FRAZIER MANAGEMENT LLC (1,051,441 shares), ARK Investment Management LLC (1,033,491 shares), FARALLON CAPITAL MANAGEMENT LLC (1,000,000 shares), WASATCH ADVISORS INC (953,368 shares), FMR LLC (765,358 shares), and STATE STREET CORP (692,408 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.